MARVER DAVID L 4
4 · Cardiac Science CORP · Filed Dec 6, 2010
Insider Transaction Report
Form 4
MARVER DAVID L
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Restricted Stock Units
2010-12-02−18,750→ 56,250 totalExercise: $0.00From: 2010-12-02Exp: 2020-12-02→ Common Stock (18,750 underlying) - Disposition to Issuer
Restricted Stock Units
2010-12-03$2.30/sh−56,250$129,375→ 0 totalExercise: $0.00From: 2010-12-02Exp: 2020-12-02→ Common Stock (56,250 underlying) - Tax Payment
Common Stock
2010-12-02$2.29/sh−4,960$11,358→ 14,315 total - Exercise/Conversion
Common Stock
2010-12-02+18,750→ 19,275 total - Disposition to Issuer
Common Stock
2010-12-03$2.30/sh−14,315$32,925→ 0 total - Disposition to Issuer
Restricted Stock Units
2010-12-03$2.30/sh−215,000$494,500→ 0 totalExercise: $0.00From: 2011-01-04Exp: 2020-01-04→ Common Stock (215,000 underlying)
Footnotes (5)
- [F1]Includes shares acquired under the issuer's employee stock purchase plan not previously reported.
- [F2]Disposed of pursuant to merger agreement between issuer and Opto Circuits (India) Ltd. at a price per share of $2.30, less any applicable tax withholding, on the effective date of the merger.
- [F3]The restricted stock units vest in four equal annual installments beginning 12/2/2010.
- [F4]This restricted stock unit award, which provided for vesting in four equal annual installments beginning 1/4/2011, was accelerated in vesting and canceled on the effective date of the merger referenced above in exchange for a cash payment of $2.30 per restricted stock unit, less any applicable tax withholding.
- [F5]This restricted stock unit award, which provided for vesting in four equal annual installments beginning 12/2/2010, was accelerated in vesting and canceled on the effective date of the merger referenced above in exchange for a cash payment of $2.30 per restricted stock unit, less any applicable tax withholding.